9 news items
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
ZOM
15 May 24
products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
ZOM
9 May 24
products, the Company's ability to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
ZOM
6 May 24
its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
ZOM
2 May 24
, the satisfaction by our strategic partners of their obligations under our commercial agreements, our ability to realize upon our business plans
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ZOM
1 Apr 24
to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners
2xvkd46lk6c4 znlp0ziymdskl7p
ZOM
14 Mar 24
, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial
794zedg9em27zb4s5pfdsxfcg9aex779md679cdi 1ugmidev4a61omslq
ZOM
13 Mar 24
of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial agreements, our
ffpakphe9lh0baakmmkadh
ZOM
12 Mar 24
, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial
13n7uahskrzahxngoss9z4zt99ps3cb01hl94syi5anvtqbn8s6nsdyl3x3
ZOM
7 Mar 24
, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial
- Prev
- 1
- Next